Yoshida T, Kumagai T, Toyozawa R, Katayama R, et al. Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial. Cancer Sci 2023 Jul 11. doi: 10.1111/cas.15888.
PMID: 37434391